These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9238187)

  • 41. Some applications of radiochromium 51Cr in assessing the value of therapeutic regimes and the effects of crises in haemoglobinopathic states.
    Knight R; Woodruff AW; Pettitt LE
    Trans R Soc Trop Med Hyg; 1968; 62(1):92-104. PubMed ID: 5639538
    [No Abstract]   [Full Text] [Related]  

  • 42. Emerging 'A' therapies in hemoglobinopathies: agonists, antagonists, antioxidants, and arginine.
    Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2012; 2012():271-5. PubMed ID: 23233591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydroxyurea therapy in highly unstable hemoglobin carriers.
    Rose C; Bauters F; Galacteros F
    Blood; 1996 Oct; 88(7):2807-8. PubMed ID: 8839880
    [No Abstract]   [Full Text] [Related]  

  • 44. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ; Charache S; Boyer SH
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract]   [Full Text] [Related]  

  • 45. Reversing ontogeny.
    Bunn HF
    N Engl J Med; 1993 Jan; 328(2):129-31. PubMed ID: 7677964
    [No Abstract]   [Full Text] [Related]  

  • 46. The evolving role of DNA demethylating agents in the treatment of sickle cell disease and thalassemia.
    DeSimone J
    Semin Hematol; 2004 Oct; 41(4 Suppl 6):1-3. PubMed ID: 15799099
    [No Abstract]   [Full Text] [Related]  

  • 47. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
    Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
    N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antithrombin III and congenital hemolytic anemia].
    Giustolisi R; Musso R; Cacciola E
    Haematologica; 1990; 75 Suppl 2():54-63. PubMed ID: 2387552
    [No Abstract]   [Full Text] [Related]  

  • 49. Erythropoietin and hemoglobin switching.
    McGlave PB; Zanjani ED
    Tex Rep Biol Med; 1980-1981; 40():125-35. PubMed ID: 6172863
    [No Abstract]   [Full Text] [Related]  

  • 50. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Erythropoietin stimulates F-reticulocyte formation in sickle cell anemia.
    al-Khatti A; Umemura T; Clow J; Abels RI; Vance J; Papayannopoulou T; Stamatoyannopoulos G
    Trans Assoc Am Physicians; 1988; 101():54-61. PubMed ID: 2480020
    [No Abstract]   [Full Text] [Related]  

  • 52. Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked.
    Farmakis D; Aessopos A
    Circulation; 2011 Mar; 123(11):1227-32. PubMed ID: 21422398
    [No Abstract]   [Full Text] [Related]  

  • 53. Hemoglobinopathies among five major ethnic groups in Karachi, Pakistan.
    Ghani R; Manji MA; Ahmed N
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):855-61. PubMed ID: 12757239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. delta beta-Thalassemia and HPFH.
    Ottolenghi S; Giglioni B; Taramelli R; Comi P; Gianni AM
    Birth Defects Orig Artic Ser; 1982; 18(7):65-7. PubMed ID: 6186314
    [No Abstract]   [Full Text] [Related]  

  • 55. [Study of fetal hemoglobin levels in different forms of drepanocytosis].
    Orsini A; Vovan L; Perrimond H
    Arch Fr Pediatr; 1972 Apr; 29(4):443-4. PubMed ID: 5053220
    [No Abstract]   [Full Text] [Related]  

  • 56. Future prospects for treatment of hemoglobinopathies.
    Stamatoyannopoulos JA
    West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Newborn screening for sickle cell disease and other hemoglobinopathies. Northern California's experience.
    Hurst D
    Pediatrics; 1989 May; 83(5 Pt 2):868-71. PubMed ID: 2541400
    [No Abstract]   [Full Text] [Related]  

  • 58. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    J Clin Invest; 1984 Aug; 74(2):652-6. PubMed ID: 6205021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sickle-cell thalassaemia disease in Sudanese.
    Ibrahim SA
    East Afr Med J; 1970 Jan; 47(1):47-9. PubMed ID: 5436179
    [No Abstract]   [Full Text] [Related]  

  • 60. Hereditary persistence of fetal haemoglobin.
    Weatherall DJ; Clegg JB
    Br J Haematol; 1975 Feb; 29(2):191-8. PubMed ID: 1103943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.